LR Trademark

Trademark Overview


On Monday, June 15, 2020, a trademark application was filed for LR with the United States Patent and Trademark Office. The USPTO has given the LR trademark a serial number of 90002557. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by Shanghai Liangrun Biomedicine Technology Co.,Ltd.. The LR trademark is filed in the Chemical Products category with the following description:

Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields
lr

General Information


Serial Number90002557
Word MarkLR
Filing DateMonday, June 15, 2020
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6239462
Registration DateTuesday, January 5, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 20, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBiochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields
Description of MarkThe mark consists of a design element of "L" and "R" letters in a shaded circle.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, July 13, 2020
Primary Code001
First Use Anywhere DateWednesday, July 19, 2017
First Use In Commerce DateWednesday, April 22, 2020

Trademark Owner History


Party NameShanghai Liangrun Biomedicine Technology Co.,Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressShanghai 200000
CN

Party NameShanghai Liangrun Biomedicine Technology Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShanghai 200000
CN

Party NameShanghai Liangrun Biomedicine Technology Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 200000
CN

Trademark Events


Event DateEvent Description
Thursday, June 18, 2020NEW APPLICATION ENTERED
Monday, July 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 14, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, September 14, 2020ASSIGNED TO EXAMINER
Monday, September 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2020PUBLISHED FOR OPPOSITION
Tuesday, October 20, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021REGISTERED-PRINCIPAL REGISTER
Monday, January 5, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED